ELAVL1 and gastric cancer: Numerous researches have been presented on the modulation of miR-582-3p in cancer, for instance, miR-582-3p is available to target HUR and VEGF proteins to impact gastric cancer (GC) development [14], elevated miR-582-3p is available to repress hepatocellular carcinoma (HCC) tumor formation [15], etc. Meanwhile, miR-582-3p also acts as a sponge target by some long noncoding RNAs.